Sei Investments Co. Acquires 81,926 Shares of AdaptHealth Corp. $AHCO

Posted by George Bondi on Aug 4th, 2026

Sei Investments Co. raised its holdings in shares of AdaptHealth Corp. (NASDAQ:AHCO – Free Report) by 17.8% in the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 541,331 shares of the company’s stock after acquiring an additional 81,926 shares during the period. Sei Investments Co. owned approximately 0.40% of AdaptHealth worth $6,442,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in the stock. Rockefeller Capital Management L.P. boosted its position in shares of AdaptHealth by 433.0% in the 4th quarter. Rockefeller Capital Management L.P. now owns 2,585 shares of the company’s stock worth $26,000 after purchasing an additional 2,100 shares during the last quarter. PNC Financial Services Group Inc. grew its position in shares of AdaptHealth by 22.3% during the 4th quarter. PNC Financial Services Group Inc. now owns 7,003 shares of the company’s stock worth $70,000 after buying an additional 1,279 shares during the period. Assetmark Inc. grew its position in shares of AdaptHealth by 54.8% during the 1st quarter. Assetmark Inc. now owns 6,952 shares of the company’s stock worth $83,000 after buying an additional 2,460 shares during the period. Tower Research Capital LLC TRC increased its stake in shares of AdaptHealth by 318.0% in the 2nd quarter. Tower Research Capital LLC TRC now owns 9,592 shares of the company’s stock valued at $90,000 after acquiring an additional 7,297 shares during the last quarter. Finally, Tidal Investments LLC bought a new stake in shares of AdaptHealth in the 2nd quarter valued at about $96,000. Institutional investors and hedge funds own 82.67% of the company’s stock.

AdaptHealth Price Performance

Shares of NASDAQ AHCO opened at $10.83 on Tuesday. The company has a fifty day moving average price of $10.29 and a 200 day moving average price of $10.68. The firm has a market cap of $1.47 billion, a PE ratio of -17.47, a PEG ratio of 0.55 and a beta of 1.47. The company has a current ratio of 0.92, a quick ratio of 0.71 and a debt-to-equity ratio of 1.21. AdaptHealth Corp. has a 1-year low of $8.51 and a 1-year high of $13.43.

Analyst Ratings Changes

Several research firms recently weighed in on AHCO. Royal Bank Of Canada lifted their price objective on shares of AdaptHealth from $13.00 to $15.00 and gave the stock an “outperform” rating in a research note on Monday, May 11th. Wall Street Zen raised shares of AdaptHealth from a “hold” rating to a “buy” rating in a research note on Sunday, June 14th. Jefferies Financial Group upgraded shares of AdaptHealth from a “hold” rating to a “buy” rating and increased their target price for the stock from $11.00 to $13.00 in a report on Tuesday, July 21st. Truist Financial upped their price objective on shares of AdaptHealth from $13.00 to $14.00 and gave the company a “buy” rating in a research report on Monday, April 13th. Finally, UBS Group dropped their price objective on AdaptHealth from $15.00 to $14.00 and set a “buy” rating on the stock in a research note on Wednesday, May 6th. Seven research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $14.14.

Check Out Our Latest Report on AdaptHealth

Insider Activity at AdaptHealth

In other news, insider Russell E. Schuster III sold 11,275 shares of the company’s stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $10.06, for a total transaction of $113,426.50. Following the completion of the transaction, the insider directly owned 136,538 shares of the company’s stock, valued at $1,373,572.28. This represents a 7.63% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.95% of the stock is currently owned by company insiders.

AdaptHealth Company Profile

(Free Report)

AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.